AAAAAA
Results:
1-19
|
Results: 19
Authors:
GRIMWADE D
JAMAL R
GOULDEN N
KEMPSKI H
MASTRANGELO S
VEYS P
Citation: D. Grimwade et al., SALVAGE OF PATIENTS WITH ACUTE PROMYELOCYTIC LEUKEMIA WITH RESIDUAL DISEASE FOLLOWING ABMT PERFORMED IN 2ND CR USING ALL-TRANS-RETINOIC ACID, British Journal of Haematology, 103(2), 1998, pp. 559-562
Authors:
LANGABEER SE
GRIMWADE D
WALKER H
ROGERS JR
BURNETT AK
GOLDSTONE AH
LINCH DC
Citation: Se. Langabeer et al., A STUDY TO DETERMINE WHETHER TRISOMY-8, DELETED 9Q AND TRISOMY-22 AREMARKERS OF CRYPTIC REARRANGEMENTS OF PML RAR-ALPHA, AML1/ETO AND CBFB/MYH11 RESPECTIVELY IN ACUTE MYELOID-LEUKEMIA/, British Journal of Haematology, 101(2), 1998, pp. 338-340
Authors:
LANGABEER SE
ALLFORD S
GRIMWADE D
CHATTERS SJ
WALKER H
OLIVER FJ
ROGERS JR
ARNOLD J
BAIN BJ
KILBY AM
GOLDSTONE AH
BURNETT AK
PATTERSON KG
LINCH DC
Citation: Se. Langabeer et al., 2 CASES OF T(15-17) NOT ASSOCIATED WITH APL AND THE VALUE OF MOLECULAR SCREENING FOR PML RAR-ALPHA IN AML/, British Journal of Haematology, 101, 1998, pp. 42-42
Authors:
IQBAL S
GRIMWADE D
CHASE A
GOLDSTONE AH
BURNETT AK
GOLDMAN JM
SWIRSKY D
Citation: S. Iqbal et al., IDENTIFICATION OF PML RAR-ALPHA REARRANGEMENTS IN SUSPECTED ACUTE PROMYELOCYTIC LEUKEMIA (APL) USING IN-SITU HYBRIDIZATION ON BONE-MARROW (BM) SMEARS - A COMPARISON OF CYTOGENETICS WITH RT-PCR IN MRC ATRA TRIAL PATIENTS/, British Journal of Haematology, 101, 1998, pp. 56-56
Authors:
GRIMWADE D
LANGABEER S
HOWE K
WALKER H
WHEATLEY K
HARRISON G
GOLDSTONE A
BURNETT A
SOLOMON E
Citation: D. Grimwade et al., THE ROLE OF MOLECULAR DIAGNOSIS AND RESIDUAL DISEASE MONITORING IN APL - RESULTS OF THE MRC ATRA TRIAL, British Journal of Haematology, 101, 1998, pp. 322-322
Authors:
CULLIGAN DJ
STEVENSON D
CHEE YL
GRIMWADE D
Citation: Dj. Culligan et al., ACUTE PROMYELOCYTIC LEUKEMIA WITH T(11-17)(Q23-Q12-21) AND A GOOD INITIAL RESPONSE TO PROLONGED ATRA AND COMBINATION CHEMOTHERAPY, British Journal of Haematology, 100(2), 1998, pp. 328-330
Authors:
GRIMWADE D
WALKER H
OLIVER F
WHEATLEY K
HARRISON C
HARRISON G
REES J
HANN I
STEVENS R
BURNETT A
GOLDSTONE A
Citation: D. Grimwade et al., THE IMPORTANCE OF DIAGNOSTIC CYTOGENETICS ON OUTCOME IN AML - ANALYSIS OF 1,612 PATIENTS ENTERED INTO THE MRC-AML-10 TRIAL, Blood, 92(7), 1998, pp. 2322-2333
Authors:
HODGES M
TISSOT C
HOWE K
GRIMWADE D
FREEMONT PS
Citation: M. Hodges et al., STRUCTURE, ORGANIZATION, AND DYNAMICS OF PROMYELOCYTIC LEUKEMIA PROTEIN NUCLEAR-BODIES, American journal of human genetics, 63(2), 1998, pp. 297-304
Authors:
GRIMWADE D
WALKER H
OLIVER F
WHEATLEY K
CLACK R
BURNETT A
GOLDSTONE A
Citation: D. Grimwade et al., WHAT HAPPENS SUBSEQUENTLY IN AML WHEN CYTOGENETIC ABNORMALITIES PERSIST AT BONE-MARROW HARVEST - RESULTS OF THE 10TH UK MRC AML TRIAL, Bone marrow transplantation, 19(11), 1997, pp. 1117-1123
Authors:
EVANS G
GRIMWADE D
PRENTICE HG
SIMPSON N
Citation: G. Evans et al., CENTRAL-NERVOUS-SYSTEM RELAPSE IN ACUTE PROMYELOCYTIC LEUKEMIA IN PATIENTS TREATED WITH ALL-TRANS-RETINOIC ACID, British Journal of Haematology, 98(2), 1997, pp. 437-439
INFLUENCE OF GENETIC PREDISPOSITION TO THROMBOSIS ON NATURAL-HISTORY OF ACUTE PROMYELOCYTIC LEUKEMIA
Authors:
REES D
GRIMWADE D
LANGABEER S
BURNETT A
GOLDSTONE A
Citation: D. Rees et al., INFLUENCE OF GENETIC PREDISPOSITION TO THROMBOSIS ON NATURAL-HISTORY OF ACUTE PROMYELOCYTIC LEUKEMIA, British Journal of Haematology, 96(3), 1997, pp. 490-492
CHARACTERIZATION OF CRYPTIC REARRANGEMENTS AND VARIANT TRANSLOCATIONSIN ACUTE PROMYELOCYTIC LEUKEMIA
Authors:
GRIMWADE D
GORMAN P
DUPREZ E
HOWE K
LANGABEER S
OLIVER F
WALKER H
CULLIGAN D
WATERS J
POMFRET M
GOLDSTONE A
BURNETT A
FREEMONT P
SHEER D
SOLOMON E
Citation: D. Grimwade et al., CHARACTERIZATION OF CRYPTIC REARRANGEMENTS AND VARIANT TRANSLOCATIONSIN ACUTE PROMYELOCYTIC LEUKEMIA, Blood, 90(12), 1997, pp. 4876-4885
Authors:
GRIMWADE D
LANGABEER S
GORMAN P
HOWE K
DUPREZ E
WALKER H
WHEATLEY K
GOLDSTONE A
BURNETT A
SOLOMON E
Citation: D. Grimwade et al., MOLECULAR CHARACTERIZATION OF PATIENTS WITH APL ENTERED INTO THE UK MRC ATRA TRIAL - RELATIONSHIP OF PML BREAKPOINT WITH ADDITIONAL CYTOGENETIC ABNORMALITIES AND OUTCOME, Blood, 90(10), 1997, pp. 271-271
Authors:
GRIMWADE D
HOWE K
LANGABEER S
BURNETT A
GOLDSTONE A
SOLOMON E
Citation: D. Grimwade et al., MINIMAL RESIDUAL DISEASE DETECTION IN ACUTE PROMYELOCYTIC LEUKEMIA BYREVERSE-TRANSCRIPTASE PCR - EVALUATION OF PML-RAR-ALPHA AND RAR-ALPHA-PML ASSESSMENT IN PATIENTS WHO ULTIMATELY RELAPSE, Leukemia, 10(1), 1996, pp. 61-66
Authors:
GRIMWADE D
HOWE K
LANGABEER S
DAVIES L
OLIVER F
WALKER H
SWIRSKY D
WHEATLEY K
GOLDSTONE A
BURNETT A
SOLOMON E
Citation: D. Grimwade et al., ESTABLISHING THE PRESENCE OF THE T(15-17) IN SUSPECTED ACUTE PROMYELOCYTIC LEUKEMIA - CYTOGENETIC, MOLECULAR AND PML IMMUNOFLUORESCENCE ASSESSMENT OF PATIENTS ENTERED INTO THE MRC ATRA TRIAL, British Journal of Haematology, 94(3), 1996, pp. 557-573
Authors:
GRIMWADE D
DAVIES L
HOWE K
BODDY M
LANGABEER S
WALKER H
SMITH F
WHEATLEY K
SWIRSKY D
GOLDSTONE A
BURNETT A
SOLOMON E
Citation: D. Grimwade et al., ESTABLISHING THE PRESENCE OF T(15-17) IN PATIENTS WITH SUSPECTED APL,ENTERED INTO THE MRC ATRA STUDY, BY PML IMMUNOFLUORESCENCE STAINING, British Journal of Haematology, 93, 1996, pp. 203-203
Authors:
GRIMWADE D
WALKER H
HARRISON C
OLIVER F
WHEATLEY K
HARRISON G
GRAY R
HANN I
STEVENS R
REES J
GOLDSTONE A
BURNETT A
Citation: D. Grimwade et al., IMPACT OF DIAGNOSTIC CYTOGENETICS ON OUTCOME IN AML - ANALYSIS OF 1,613 PATIENTS ENTERED INTO THE UK MRC AML 10 TRIAL, Blood, 88(10), 1996, pp. 2525-2525
Authors:
REES DC
CERVI P
GRIMWADE D
ODRISCOLL A
HAMILTON M
PARKER NE
PORTER JB
Citation: Dc. Rees et al., THE METABOLITES OF NITRIC-OXIDE IN SICKLE-CELL DISEASE, British Journal of Haematology, 91(4), 1995, pp. 834-837
Authors:
GRIMWADE D
HOWE K
LANGABEER S
WALKER H
SMITH F
SWIRSKY D
WHEATLEY K
GOLDSTONE A
BURNETT A
SOLOMON E
Citation: D. Grimwade et al., MOLECULAR AND CYTOGENETIC ASSESSMENT OF PATIENTS WITH ACUTE PROMYELOCYTIC LEUKEMIA (APL) ENTERED INTO THE UK MRC ATRA TRIAL, Blood, 86(10), 1995, pp. 1060-1060
Risultati:
1-19
|